PURE Bioscience Q3 Net Loss Widens to $624K on $506K Revenue
Reported by Wiseek News
Sentiment
Negative
Importance
7
Price
$0.07
Mkt Cap
$9.101M
52W Low
$0.039
52W High
$0.214
Market data snapshot near publication time
Summary
PURE Bioscience reported a Q3 2026 net loss of $624K, which widened from $580K in the prior year, despite a modest 3.5% increase in revenue to $506K. This update, summarizing the 10-Q filed earlier today, confirms the company's continued financial struggles. The increased net loss for this micro-cap company, alongside previously disclosed going concern doubts, indicates ongoing operational challenges.
At the time of this announcement, PURE was trading at $0.07 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $9.1M. The 52-week trading range was $0.04 to $0.21. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.
Price Chart
PURE - Latest Insights
PURE
Jun 15, 2026, 4:21 PM EDT
Price at Filing:
$0.070
Real-time Price:
$0.070
Change:
$0 (0%)
Market Cap:
$9.101M
PURE
Jun 15, 2026, 4:10 PM EDT
Price at Filing:
$0.070
Real-time Price:
$0.070
Change:
$0 (0%)
Market Cap:
$9.101M
PURE
Jun 15, 2026, 4:05 PM EDT
Price at Filing:
$0.070
Real-time Price:
$0.070
Change:
$0 (0%)
Market Cap:
$9.101M
PURE
May 05, 2026, 5:13 PM EDT
Price at Filing:
$0.067
Real-time Price:
$0.070
Change:
+$0.0030 (+4%)
Market Cap:
$9.101M
PURE
May 05, 2026, 5:10 PM EDT
Price at Filing:
$0.067
Real-time Price:
$0.070
Change:
+$0.0030 (+4%)
Market Cap:
$9.101M
PURE
Mar 16, 2026, 9:29 PM EDT
Price at Filing:
$0.080
Real-time Price:
$0.070
Change:
-$0.0100 (-12%)
Market Cap:
$9.101M
PURE
Mar 16, 2026, 9:24 PM EDT
Price at Filing:
$0.080
Real-time Price:
$0.070
Change:
-$0.0100 (-12%)
Market Cap:
$9.101M
PURE
Feb 20, 2026, 4:49 PM EST
Price at Filing:
$0.05672
Real-time Price:
$0.070
Change:
+$0.01328 (+23%)
Market Cap:
$9.101M